Issue
Vol 1 · Issue 3 · April 2026
April 2026 · 5 articles.
Clinical Research
OnabotulinumtoxinA (Botox) for Migraine Prevention: Why Neurology Uses 31–39 Injection Sites and 155–195 Units
Harley Street Institute Clinical Review Board
Evidence-based review of the PREEMPT protocol, NICE TA260 commissioning, and randomised trial evidence on lower-dose or anterior-only botulinum toxin strategies for chronic and episodic migraine.
Published 30 Apr 20261 AiCE pointFull text
Clinical Research
Combining Botulinum Toxin and Corticosteroid Injections for Trigger Point Management
Harley Street Institute Clinical Review Board
Evidence-based clinical review examining whether botulinum toxin and corticosteroid should be combined for trigger point injections, with RCT evidence, guidelines, dosing and decision algorithm.
Published 28 Apr 20261 AiCE pointFull text
Clinical Practice
Chin Deficiency Classification and Filler Treatment: A Practical Injector Framework Using Ricketts' E‑Line Analysis
Harley Street Institute Clinical Review Board
Clinical review presenting a structured classification system for chin deficiency with evidence-based filler treatment algorithms, product selection guidance and gender-specific treatment planning.
Published 21 Apr 20261 AiCE pointFull text
Literature Review
Skin Booster Modalities in Aesthetic Dermatology: Mechanisms, Evidence, Safety, Protocols, and Sequencing
Harley Street Institute Editorial Board
Clinician-facing review comparing six skin booster domains — polynucleotides, PRP, retinoids, peptides, exosomes, and amino-acid/HA biorevitalisers — evaluating mechanisms, evidence, safety, and sequencing protocols.
Published 14 Apr 20261 AiCE pointFull text
Clinical Research
Botulinum Toxin Type A in Orofacial Pain Management: A Clinical Review
Harley Street Institute Clinical Review Board
Evidence-based clinical review of botulinum toxin type A for TMD, myofascial pain, and bruxism-associated orofacial pain with RCT evidence and injection protocols.
Published 7 Apr 20261 AiCE pointFull text